- Introduction to Clinical Research Training
- Medical Education
- Vanderbilt Hall
- Financial Aid
- Office of the Registrar
- Campus Planning and Facilities
- Ombuds Office
- Committee on Microbiological Safety
- Human Resources
- HMS Foundation Funds
- Office for Academic and Clinical Affairs
- Joint Committee on the Status of Women
- The Academy
- Global Health Research Core
- Global Clinical Scholars Research Training Program
- HMA Standing Committee on Animals
- Office of Research Compliance
- Global & Community Health
- Harvard Medical School Event Calendar
- Contact @HMS
- Office of Diversity RIA Program
- Q&A Archive
- The Dean's Perspective
- Department of Pathology
- HMS NEXT
- Harvard Mahoney Neuroscience Institute
- OHRA Home
- Office of Research Subject Protection
- Tools and Technology
- Alumni Association
- HMS Information Technology
- HMS TransMed Program
- Office of Communications & External Relations
- test page
- Human Resources
- Jobs @ HMS
- Contact us
- Dental Medicine
- Harvard University
June 4, 2014
Young adults who lack health care insurance are more likely to be diagnosed in advanced stages of cancer and have a higher risk of death, according to a study from Harvard Medical School and Dana-Farber/Brigham and Women’s Cancer Center.
Consequently, the Affordable Care Act may improve cancer outcomes in young adults as it expands coverage to many who have been uninsured, said first author Ayal Aizer, HMS clinical fellow in radiation oncology at Brigham and Women’s Hospital, and senior author Paul Nguyen, HMS associate professor of radiation oncology at DF/BWCC, in a report published June 2 in the Journal of Clinical Oncology.
Cancer patients will also benefit from the ACA requirement that insurers cover individuals with pre-existing conditions, the authors said.
“We found that patients who have insurance coverage do better on every measure,” said Aizer.
Those who had insurance coverage were less likely to seek medical attention when their cancer had metastasized, or spread beyond the original site.
The results showed that 11.3 percent of covered individuals had metastatic disease when they were diagnosed, compared with 18.5 percent of uninsured patients. That amounted to a 16 percent greater adjusted likelihood of having a potentially curable cancer.
Insured patients were about twice as likely to receive “definitive therapy”—radiation or surgery—for their disease. And, strikingly, the insured were 20 percent more likely to survive.
The researchers analyzed records of 39,447 cancer patients ages 20 to 40 years whose medical, demographic and insurance information was stored in a National Cancer Institute-sponsored database.
The vast majority of patients—93 percent—were insured, while 7 percent, or 2,578 patients, lacked coverage.
Uninsured patients tended to be younger, male, non-white, unmarried and more likely to be from regions of lower median income, educational level and population density.
The study examined relationships between insurance status and several cancer outcomes.
“Overall, the ACA is going to improve health coverage for young people, but we can’t forget about some young people who may feel they can’t afford the premiums,” added Nguyen.
The authors wrote in their article that “extra consideration will need to be given to ensure that at-risk patients can obtain insurance coverage under the ACA.”
Premium costs for some young adults who purchase insurance in the individual market are expected to rise substantially. Such individuals often lack employer-sponsored health plans.
The higher costs are partly because the coverage under the ACA is required to be more comprehensive than many existing plans, and because the premiums paid by young healthy people are helping to subsidize lower costs for older adults.
On the other hand, the ACA extends young adults’ coverage under their parents’ health plans until age 26, and federal subsidies will pay part of the premium costs of low-earning consumers.
Aizer said the study was aimed at exploring the ACA’s potential impact on cancer outcomes. The law expands public and private insurance coverage to many previously uninsured patients, requires that all individuals obtain coverage or pay an annual fine and applies new minimum standards to health policies.
The research was funded by a Heritage Medical Research Institute/Prostate Cancer Foundation Young Investigator Award and other private and foundation grants.
Adapted from a Dana-Farber news release.